Ionis Pharmaceuticals, Inc. (ISI)
XSTU
Real-time Data
06:00 AM
Day's Range
38.9352 wk Range
37.71Overview - ISI - Ionis Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
12.14B
P/E (Trailing)
‪-16.55‬
Price / Sales (TTM)
‪11.07‬
EV / EBITDA
‪-31.91‬
Profitability
Gross Margin
‪98.97%‬
Profit Margin
‪98.31%‬
Operating Margin
‪-31.29%‬
Return on Assets
‪-10.82%‬
Return on Equity
‪-77.97%‬
Ownership
Shares Outstanding
165.90M
Price stats
50-Day Avg
‪68.40‬
200-Day Avg
‪49.92‬
Market Cap - ISI - Ionis Pharmaceuticals, Inc.
Peers - ISI - Ionis Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- ISIXSTUIonis Pharmaceuticals, Inc.10.45BMarket Cap-52.12%52-week change-16.55P/E (Trailing)‪98.31%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+6.26%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech, Inc.8.99BMarket Cap+52.99%52-week change43.02P/E (Trailing)‪54.81%‬Profit Margin
- 19XXSTUAxsome Therapeutics Inc.7.98BMarket Cap+41.36%52-week change-46.29P/E (Trailing)‪92.56%‬Profit Margin
- 2X10XSTUAbivax SA Sponsored ADR7.19BMarket Cap+12.50%52-week change-16.56P/E (Trailing)‪0.00%‬Profit Margin
- 30JXSTUIDEAYA Biosciences Inc.3.10BMarket Cap+29.17%52-week change-25.15P/E (Trailing)‪-74.75%‬Profit Margin
- BSFAXSTUAni Pharmaceuticals, Inc.1.49BMarket Cap-19.23%52-week change16.21P/E (Trailing)‪11.07%‬Profit Margin
Profile Summary - ISI - Ionis Pharmaceuticals, Inc.
About
Ionis Pharmaceuticals, Inc. is a commercial-stage biotechnology company focused on discovering and developing RNA-targeted medicines. Using its proprietary antisense technology, Ionis creates therapies designed to modulate gene expression and address serious diseases, particularly in neurology and cardiometabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
